Innovative approaches for pediatric cancer immunotherapy
This course aims to synthesize the state-of-the-art and the therapeutic perspectives related to harnessing children's immune system to target pediatric tumors. Encompassing topics from biological characteristics of pediatric cancers and childhood immunity to cutting-edge cellular engineering developments, it will focus on pediatric solid tumors while drawing lessons from recent successes and remaining challenges in childhood hematologic malignancies. The course will bring together leading international stakeholders whose recent preclinical and clinical breakthroughs suggest promising therapeutic improvements ahead.
Objectives
- Expose participants to the latest advances in immunotherapy for pediatric cancer.
- Highlight unique aspects of pediatric cancers and childhood immunity and their relevance for diverse immunotherapy approaches
- Address developments at fundamental, preclinical, and clinical research levels
Registration deadline: November 28th, 2025
Keynote speakers
Robbie MAJZNER, US
Speakers
Franck BOURDEAUT, FR
Annelisa CORNEL, NL
Francesca DEL BUFALO, IT
Julio DELGADO, ES
Emmanuel DONNADIEU, FR
Marie Emilie DOURTHE, FR
Jaime FUENTEALBA, FR
Thomas GRUNEWALD, DE
Amaury LERUSTE, FR
Robbie MAJZNER, US
Veronique MINARD-COLIN, FR
Benedicte NEVEN, FR
Claudia PASQUALINI, FR
Naomi TAYLOR, US
Guillaume VAQUER, FR
Rein VERBEKE, BE
Eric VIVIER, FR
Joshua WATERFALL, FR
Date:
Organized by:
